Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02105350 |
Title | A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer |
Recruitment | Withdrawn |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | University Health Network, Toronto |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries |